Detalhe da pesquisa
1.
The risk and burden of thromboembolic and hemorrhagic events in patients with malignant gliomas receiving bevacizumab.
J Neurooncol
; 167(1): 181-188, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38372903
2.
Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance.
Int J Mol Sci
; 21(6)2020 Mar 13.
Artigo
Inglês
| MEDLINE | ID: mdl-32182988
3.
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients.
J Neurooncol
; 135(1): 75-81, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28702781
4.
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
Acta Neuropathol
; 129(4): 585-96, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25701198
5.
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem Cells.
Cancers (Basel)
; 13(21)2021 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-34771447
6.
A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma.
Oncotarget
; 8(52): 90488-90495, 2017 Oct 27.
Artigo
Inglês
| MEDLINE | ID: mdl-29163847
7.
iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium.
Neuro Oncol
; 22(10): 1545-1546, 2020 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-32644158